Current status of gastric and oral infection/diseases caused by Helicobacter pylori

被引:1
|
作者
Noiri, Yuichiro [1 ]
Nagata, Ryoko [1 ]
机构
[1] Niigata Univ, Fac Dent, Grad Sch Med & Dent Sci, Div Cariol Operat Dent & Endodont, 2-5274 Gakkocho Dori,Chuo Ku, Niigata 9518514, Japan
关键词
dental biofilm; H; pylori; oral cavity; stomach infection; PROTON PUMP INHIBITOR; MOTHER-TO-CHILD; 1ST-LINE ERADICATION; TRIPLE THERAPY; NONCULTURABLE STATE; DENTAL PLAQUE; CAGA; TRANSMISSION; PHOSPHORYLATION; CLARITHROMYCIN;
D O I
10.1002/osi2.1172
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Helicobacter pylori is found in the stomach, which is its optimal habitat, and is considered an important factor in various serious diseases, including stomach cancer. The World Health Organization has identified H. pylori as a causative agent of gastric cancer, as confirmed by animal experiments in rodents. The fact that H. pylori can live in the harsh environment of stomach acid was the greatest hindrance to the discovery of H. pylori. It was not so long ago, in 1983, that it was successfully isolated and cultured. Subsequently, H. pylori eradication therapy was established, and it became possible to control gastric cancer to some extent. However, the mechanism, route, and mode of H. pylori infection still remain unclear. Furthermore, currently, the prevention of first-episode gastric cancer and control of recurrent gastric cancer are not perfect. One of the reasons for this may be that the status of H. pylori in the oral cavity, which is the entry point for the organism (the beginning of the digestive system: the first route of infection), is still unknown. Therefore, we reviewed the current status of H. pylori infection in the stomach and oral cavity, focusing on (1) the mechanism of infection, (2) pathogenic factors, (3) the actual status of eradication therapy, and (4) control strategies.
引用
收藏
页码:182 / 189
页数:8
相关论文
共 50 条
  • [21] Antibodies to Helicobacter pylori in gastric diseases
    Lazebnik, LB
    Tsaregorodtseya, TM
    Serova, TI
    Sokolova, GN
    Klishina, MV
    Gubina, AV
    TERAPEVTICHESKII ARKHIV, 2006, 78 (02) : 15 - 19
  • [22] THE STATUS OF COEXISTING HELICOBACTER-PYLORI INFECTION AND GASTRIC-CARCINOMA
    LAM, S
    BANK, S
    ESPOSITO, M
    GREENBERG, R
    BLUMSTEIN, M
    CHOW, K
    GASTROENTEROLOGY, 1994, 106 (04) : A118 - A118
  • [23] Inadequate Reporting of Helicobacter pylori Infection Status in Gastric Adenocarcinoma Resections
    Rishi, A.
    Cornish, T. C.
    Park, J. Y.
    MODERN PATHOLOGY, 2014, 27 : 510A - 511A
  • [24] Serum Zinc Status and Helicobacter Pylori Infection in Gastric Disease Patients
    Zhang, Wen-Hua
    Wu, Xiao-Jing
    Niu, Jing-Xiu
    Yan, Hao
    Wang, Xin-Zhuo
    Yin, Xiao-Dong
    Pang, Yan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (10) : 5043 - 5046
  • [25] Inadequate Reporting of Helicobacter pylori Infection Status in Gastric Adenocarcinoma Resections
    Rishi, A.
    Cornish, T. C.
    Park, J. Y.
    LABORATORY INVESTIGATION, 2014, 94 : 510A - 511A
  • [26] Is IBD Caused by a Helicobacter pylori Infection?
    Fallone, Carlo A.
    Bitton, Alain
    INFLAMMATORY BOWEL DISEASES, 2008, 14 : S37 - S38
  • [27] Gastric hyperplastic polyps inversely associated with current Helicobacter pylori infection
    Yu, Xinjuan
    Wang, Zhengqiang
    Wang, Lili
    Meng, Xinying
    Zhou, Changhong
    Xin, Yongning
    Sun, Weili
    Dong, Quanjiang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (04) : 3143 - 3149
  • [28] Helicobacter pylori infection and gastric cancer
    Matysiak-Budnik, T
    Mégraud, F
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (06) : 708 - 716
  • [29] Helicobacter pylori infection and gastric cancer
    Sugiyama T.
    Asaka M.
    Medical Electron Microscopy, 2004, 37 (3): : 149 - 157
  • [30] Helicobacter pylori infection and gastric cancer
    Correa, P
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (03) : 238S - 241S